No full text
Article (Scientific journals)
Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease.
Bardsley, P. A.; Howard, P.; DeBacker, W. et al.
1991In European Respiratory Journal, 4 (3), p. 308-10
Peer Reviewed verified by ORBi
 

Files


Full Text
No document available.

Send to



Details



Keywords :
Almitrine/administration & dosage/adverse effects/therapeutic use; Anoxia/blood/drug therapy; Carbon Dioxide/blood; Double-Blind Method; Female; Humans; Lung Diseases, Obstructive/drug therapy/mortality; Male; Middle Aged; Oxygen/blood
Abstract :
[en] Eighty nine patients with hypoxic chronic obstructive airways disease (COAD) were enrolled into the 1 year Vectarion International Multicentre Study-VIMS in 4 centres, Sheffield (UK), and Antwerp, Liege and Namur (Belgium). At the end of the year the remainder were invited to continue taking placebo or almitrine bismesylate (100-200 mg daily) in the same double blind manner for a further 12 months. In the almitrine treated patients mean arterial oxygen tension (Pao2) at the end of the treatment period improved from 7.5 (0.5) kPa to 8.2 (1.3) kPa (p less than 0.01) and arterial carbon dioxide tension (Paco2) fell from 6.1 (0.8) kPa to 5.8 (0.9) kPa (p less than 0.01). Forced expiratory volume in one second (FEV1), forced vital capacity (FVC) and measurements of breathlessness were unchanged. In the placebo treated group changes in the above variables were not significant. Twenty nine patients withdrew from the almitrine group with seven deaths and six cases of peripheral neuropathy, and 22 patients withdrew from the placebo group with six deaths and two cases of peripheral neuropathy. Death rates between the groups were not significantly different. In conclusion, 2 yrs of almitrine treatment (100-200 mg daily) leads to a persistent slight improvement in PaO2 and PaCO2 but no benefit in survival was demonstrated. Patients in this study had a high incidence of drug related side-effects. Lower dose schedules should be investigated.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Bardsley, P. A.
Howard, P.
DeBacker, W.
Vermeire, P.
Mairesse, M.
Ledent, C.
Radermecker, Maurice ;  Université de Liège - ULiège > Relations académiques et scientifiques (Médecine)
Bury, Thierry ;  Université de Liège - ULiège > Département des sciences de la motricité > Physiologie humaine et physiologie de l'effort physique
Ansquer, J.
Language :
English
Title :
Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease.
Publication date :
1991
Journal title :
European Respiratory Journal
ISSN :
0903-1936
eISSN :
1399-3003
Publisher :
European Respiratory Society, United Kingdom
Volume :
4
Issue :
3
Pages :
308-10
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 28 April 2014

Statistics


Number of views
30 (1 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
19
Scopus citations®
without self-citations
19

Bibliography


Similar publications



Contact ORBi